1.
Int J Lepr Other Mycobact Dis
; 71(1): 18-21, 2003 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12914130
RESUMO
This is the first report of secondary resistance to rifampin following MDT in a patient with prolonged, but irregular treatment. Repeated mouse foot-pad studies demonstrated resistance to dapsone after several years of monotherapy, and following subsequent MDT the studies demonstrated the development of resistance to rifampin.